Bio-Thera Solutions (688177.SH) incurred a net loss of 509 million yuan in 2024, with the loss expanding.

Bio-Thera Solutions (688177.SH) released its 2024 annual performance report. The company's total operating income in 2024 was 743 million yuan, a year-on-year increase of 5.44%. The net loss attributable to the owners of the parent company was 509 million yuan, with losses expanding. The net loss attributable to the owners of the parent company, excluding non-recurring gains and losses, was 554 million yuan, with losses expanding. Basic loss per share was 1.23 yuan.